Related Experiment Video
Updated: Jan 2, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Aberrantly expressed microRNAs and their implications in childhood central nervous system tumors
Julia Alejandra Pezuk1, Karina Bezerra Salomão2, Mirella Baroni2
1Anhanguera University of São Paulo, UNIAN/SP, Av. Dr. Rudge Ramos, 1501 - Jardim Abc, São Bernardo do Campo, SP, 09639-000, Brazil.
Abstract:
Even though the treatment of childhood cancer has evolved significantly in recent decades, aggressive central nervous system (CNS) tumors are still a leading cause of morbidity and mortality in this population. Consequently, the identification of molecular targets that can be incorporated into diagnostic practice, effectively predict prognosis, follow treatment response, and materialize into potential targeted therapeutic approaches are still warranted. Since the first evidence of the participation of miRNAs in cancer development and progression 20 years ago, notable progress has been made in the basic understanding of the contribution of their dysregulation as epigenetic driver of tumorigenesis. Nevertheless, among the plethora of articles in the literature, microRNA profiling of pediatric tumors are scarce. This article gives an overview of the recent advances in the diagnostic/prognostic potential of miRNAs in a selection of pediatric CNS tumors: medulloblastoma, ependymoma, pilocytic astrocytoma, glioblastoma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumors, and choroid plexus tumors.
Insights
MicroRNAs (miRNAs) show promise as biomarkers for pediatric central nervous system (CNS) tumors. Further research into miRNA profiling can improve diagnosis, prognosis, and targeted therapies for these aggressive childhood cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Childhood central nervous system (CNS) tumors remain a significant cause of mortality despite treatment advances.
- Identifying molecular targets is crucial for improved diagnostics, prognostics, and targeted therapies.
- MicroRNAs (miRNAs) are increasingly recognized for their role in cancer development and progression.
Purpose of the Study:
- To provide an overview of recent advances in the diagnostic and prognostic potential of miRNAs in pediatric CNS tumors.
- To highlight the scarcity of microRNA profiling studies in pediatric tumors.
- To explore the role of miRNA dysregulation as an epigenetic driver of tumorigenesis.
Main Methods:
- Literature review of recent advances in miRNA research for pediatric CNS tumors.
- Focus on specific tumor types: medulloblastoma, ependymoma, pilocytic astrocytoma, glioblastoma, diffuse intrinsic pontine glioma, atypical teratoid/rhabdoid tumors, and choroid plexus tumors.
- Analysis of the diagnostic, prognostic, and therapeutic implications of miRNA dysregulation.
Main Results:
- MicroRNA dysregulation is implicated as an epigenetic driver in tumorigenesis.
- Recent advances demonstrate the diagnostic and prognostic potential of miRNAs in various pediatric CNS tumors.
- MicroRNA profiling offers a promising avenue for targeted therapeutic strategies.
Conclusions:
- MicroRNAs hold significant potential as biomarkers for pediatric CNS tumors.
- Further microRNA profiling studies are warranted to fully elucidate their role in diagnosis, prognosis, and treatment response.
- Targeted therapies based on miRNA modulation could revolutionize childhood CNS cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs

